These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 27329430)
1. Reduction of carbamylated albumin by extended hemodialysis. Perl J; Kalim S; Wald R; Goldstein MB; Yan AT; Noori N; Kiaii M; Wenger J; Chan C; Thadhani RI; Karumanchi SA; Berg AH Hemodial Int; 2016 Oct; 20(4):510-521. PubMed ID: 27329430 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis. Kalim S; Trottier CA; Wenger JB; Wibecan J; Ahmed R; Ankers E; Karumanchi SA; Thadhani R; Berg AH Clin J Am Soc Nephrol; 2016 Oct; 11(10):1809-1816. PubMed ID: 27445162 [TBL] [Abstract][Full Text] [Related]
3. Phosphate mass removal during hemodialysis: a comparison between eKT/V-matched conventional and extended dialysis. Sampaio MS; Ruzany F; Dorigo DM; Suassuna JH Am J Nephrol; 2012; 36(2):121-6. PubMed ID: 22776782 [TBL] [Abstract][Full Text] [Related]
4. The Effects of Parenteral Amino Acid Therapy on Protein Carbamylation in Maintenance Hemodialysis Patients. Kalim S; Ortiz G; Trottier CA; Deferio JJ; Karumanchi SA; Thadhani RI; Berg AH J Ren Nutr; 2015 Jul; 25(4):388-92. PubMed ID: 25753604 [TBL] [Abstract][Full Text] [Related]
5. Protein Carbamylation in Peritoneal Dialysis and the Effect of Low Glucose Plus Amino Acid Solutions. Trottier C; Perl J; Freeman M; Thadhani R; Berg A; Kalim S Perit Dial Int; 2018; 38(2):149-152. PubMed ID: 29563277 [TBL] [Abstract][Full Text] [Related]
6. Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease. Drechsler C; Kalim S; Wenger JB; Suntharalingam P; Hod T; Thadhani RI; Karumanchi SA; Wanner C; Berg AH Kidney Int; 2015 Jun; 87(6):1201-8. PubMed ID: 25671766 [TBL] [Abstract][Full Text] [Related]
7. Comparative CKD risk prediction using homocitrulline and carbamylated albumin: two circulating markers of protein carbamylation. Awwad A; Rhee EP; Grams M; Choles HR; Sondheimer J; He J; Chen J; Hsu CY; Vasan RS; Kimmel PL; Wulczyn K; Berg A; Lash J; Tang M; Kalim S; BMC Nephrol; 2024 May; 25(1):185. PubMed ID: 38816682 [TBL] [Abstract][Full Text] [Related]
8. Protein Carbamylation and the Risk of ESKD in Patients with CKD. Kalim S; Zhao S; Tang M; Rhee EP; Allegretti AS; Nigwekar S; Karumanchi SA; Lash JP; Berg AH J Am Soc Nephrol; 2023 May; 34(5):876-885. PubMed ID: 36757153 [TBL] [Abstract][Full Text] [Related]
9. Correlation between urea reduction rates and serum albumin levels in patients on hemodialysis. Hertel J; Lightfoot BO; Fincher ME; McConnell KR; Caruana RJ ASAIO J; 1995; 41(3):M801-4. PubMed ID: 8573919 [TBL] [Abstract][Full Text] [Related]
10. [Results of therapeutics strategy of protein-energy wasting in chronic hemodialysis: a prospective study during 12 months]. Mpio I; Cleaud C; Arkouche W; Laville M Nephrol Ther; 2015 Apr; 11(2):97-103. PubMed ID: 25582699 [TBL] [Abstract][Full Text] [Related]
11. Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure. Berg AH; Drechsler C; Wenger J; Buccafusca R; Hod T; Kalim S; Ramma W; Parikh SM; Steen H; Friedman DJ; Danziger J; Wanner C; Thadhani R; Karumanchi SA Sci Transl Med; 2013 Mar; 5(175):175ra29. PubMed ID: 23467560 [TBL] [Abstract][Full Text] [Related]
12. The Association Between Conversion to In-centre Nocturnal Hemodialysis and Left Ventricular Mass Regression in Patients With End-Stage Renal Disease. Wald R; Goldstein MB; Perl J; Kiaii M; Yuen D; Wald RM; Harel Z; Weinstein JJ; Jakubovic B; Leong-Poi H; Kirpalani A; Leipsic J; Dacouris N; Wolf M; Yan AT Can J Cardiol; 2016 Mar; 32(3):369-77. PubMed ID: 26386732 [TBL] [Abstract][Full Text] [Related]
13. Effects of three times weekly eight-hour nocturnal hemodialysis on volume and nutritional status. Demirci C; Ozkahya M; Demirci MS; Asci G; Kose T; Colak T; Duman S; Toz H; Ergin P; Adam SM; Ok E Am J Nephrol; 2013; 37(6):559-67. PubMed ID: 23735837 [TBL] [Abstract][Full Text] [Related]
14. Effect of Nocturnal Hemodialysis versus Conventional Hemodialysis on End-Stage Renal Disease: A Meta-Analysis and Systematic Review. Liu F; Sun Y; Xu T; Sun L; Liu L; Sun W; Feng X; Ma J; Wang L; Yao L PLoS One; 2017; 12(1):e0169203. PubMed ID: 28107451 [TBL] [Abstract][Full Text] [Related]
15. Carbamylated hemoglobin as a therapeutic marker in hemodialysis. Hasuike Y; Nakanishi T; Maeda K; Tanaka T; Inoue T; Takamitsu Y Nephron; 2002 Jun; 91(2):228-34. PubMed ID: 12053058 [TBL] [Abstract][Full Text] [Related]
16. Effects of thrice-weekly in-center nocturnal vs. conventional hemodialysis on integrated backscatter of myocardial tissue. Jin X; Rong S; Mei C; Ye C; Chen J; Chen X Hemodial Int; 2011 Apr; 15(2):200-10. PubMed ID: 21395972 [TBL] [Abstract][Full Text] [Related]
17. The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease. Alves FC; Sun J; Qureshi AR; Dai L; Snaedal S; Bárány P; Heimbürger O; Lindholm B; Stenvinkel P PLoS One; 2018; 13(1):e0190410. PubMed ID: 29298330 [TBL] [Abstract][Full Text] [Related]
18. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. Ifudu O; Feldman J; Friedman EA N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143 [TBL] [Abstract][Full Text] [Related]
19. Precedent fluctuation of serum hs-CRP to albumin ratios and mortality risk of clinically stable hemodialysis patients. Hwang JC; Jiang MY; Lu YH; Wang CT PLoS One; 2015; 10(3):e0120266. PubMed ID: 25793462 [TBL] [Abstract][Full Text] [Related]
20. [Late nephrology referral influences on morbidity and mortality of hemodialysis patients. A provincial study]. Peña JM; Logroño JM; Pernaute R; Laviades C; Virto R; Vicente de Vera C Nefrologia; 2006; 26(1):84-97. PubMed ID: 16649429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]